EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Validated UPLC‐MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study

Ariane Krause Padilha Lorenzett, Tatiane Patricia Babinski, Samila Horst Peczek, Ana Paula Tartari, Jeferson Ziebarth, Andressa Zago, Thais Carla Brussulo Pereira, Rubiana Mara Mainardes iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Ariane Krause Padilha Lorenzett und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Guarapuava, Paraná, Brazil. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Temozolomide, Monoterpenes. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is among the most aggressive brain tumors, largely due to the restrictive blood–brain barrier (BBB) and limited drug bioavailability. Temozolomide (TMZ), an alkylating agent, and perillyl alcohol (POH), a monoterpene with antitumor properties, have shown promise in GBM therapy. This study developed and validated a UPLC‐MS/MS method for the simultaneous quantification of TMZ, its active metabolite 5‐aminoimidazole‐4‐carboxamide (AIC), and perillic acid (PA), the primary POH metabolite, in rat plasma and tissues. The method met FDA and EMA validation criteria, showing high selectivity, linearity ( R 2 > 0.995), accuracy (80%–120%), precision (RSD < 15%), and matrix‐specific stability across plasma, brain, liver, kidney, spleen, and lung. Following single oral doses of TMZ (2 mg/kg) and POH (47 mg/kg), pharmacokinetic analysis revealed that TMZ had the highest systemic exposure (AUC 0–24h : 8173.64 ng·h/mL) and C max (1448.64 ng/mL), while PA showed the fastest absorption (t max : 0.5 h). AIC levels confirmed efficient TMZ metabolism. Biodistribution analysis showed TMZ accumulation in the brain (~1000 ng/mL), supporting its CNS efficacy. PA was mainly distributed to liver and kidneys, with limited brain penetration. The validated method enables preclinical pharmacokinetic and tissue distribution studies, offering valuable insights into TMZ and POH behavior for GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryTemozolomideMonoterpenesAnimalsRatsChromatography, High Pressure LiquidReproducibility of ResultsRats, Sprague-DawleyMaleLinear ModelsTissue DistributionLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

bioanalytical methodbioavailabilitybiodistributionglioblastoma

Substanzen

Temozolomideperillyl alcoholMonoterpenes

Autor:innen und Institutionen

  • Laboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Guarapuava, Paraná, Brazil.
  • Department of Pharmacy, Universidade Estadual do Centro-Oeste, Guarapuava, Paraná, Brazil.

ORCID-Profile: Rubiana Mara Mainardes

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Lorenzett, A. K. P., Babinski, T. P., Peczek, S. H., Tartari, A. P., Ziebarth, J., Zago, A., Pereira, T. C. B., & Mainardes, R. M. (2025). A Validated UPLC‐MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.70253

Vancouver

Lorenzett AKP, Babinski TP, Peczek SH, Tartari AP, Ziebarth J, Zago A, et al. A Validated UPLC‐MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study. Biomedical Chromatography. 2025. doi:10.1002/bmc.70253

BibTeX
@article{Lorenzett2025,
  author = {Lorenzett, Ariane Krause Padilha and Babinski, Tatiane Patricia and Peczek, Samila Horst and Tartari, Ana Paula and Ziebarth, Jeferson and Zago, Andressa and Pereira, Thais Carla Brussulo and Mainardes, Rubiana Mara},
  title = {A Validated UPLC‐MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70253}
}
Kostenlos starten →